CAS 36798-79-5: Budralazine
Description:Budralazine is a chemical compound classified as a hydrazine derivative, primarily known for its use as an antihypertensive agent. It functions by acting as a vasodilator, helping to lower blood pressure by relaxing blood vessels. The molecular structure of Budralazine includes a hydrazine moiety, which contributes to its pharmacological activity. It is typically administered in the form of its hydrochloride salt to enhance solubility and bioavailability. Budralazine exhibits moderate lipophilicity, allowing it to penetrate biological membranes effectively. Its mechanism of action involves the inhibition of vascular smooth muscle contraction, leading to vasodilation. While it has therapeutic applications, potential side effects may include dizziness, headache, and gastrointestinal disturbances. As with many medications, careful monitoring is essential to manage any adverse reactions and ensure efficacy. Budralazine's safety profile and pharmacokinetics are important considerations in clinical settings, particularly for patients with cardiovascular conditions. Overall, Budralazine represents a significant compound in the realm of antihypertensive therapies.
Formula:C14H16N4
InChI:InChI=1S/C14H16N4/c1-10(2)8-11(3)16-18-14-13-7-5-4-6-12(13)9-15-17-14/h4-9H,1-3H3,(H,17,18)
InChI key:InChIKey=DQGFCLJXYFXXIJ-UHFFFAOYSA-N
SMILES:N=1N=C(NN=C(C=C(C)C)C)C=2C=CC=CC2C1
- Synonyms:
- 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone
- 1-(2-(1,3-Dimethyl-2-Butenylidene)Hydrazino)Phthalazine
- 1-[(2E)-2-(1,3-dimethylbut-2-en-1-ylidene)hydrazino]phthalazine
- 1-[2-(1,3-Dimethyl-2-buten-1-ylidene)hydrazino]phthalazine
- 1-[2-(4-Methylpent-3-En-2-Ylidene)Hydrazinyl]Phthalazine
- 3-Penten-2-one, 4-methyl-, 2-(1-phthalazinyl)hydrazone
- Buterazine
- Dj 1461
- Budralazine
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Budralazine REF: TR-B689515CAS: 36798-79-5 | - - - | 352.00 €~2,322.00 € | Fri 13 Jun 25 |
![]() | Budralazine REF: TM-T23834CAS: 36798-79-5 | 98% | 908.00 €~2,375.00 € | Mon 23 Jun 25 |
![]() | Budralazine REF: 3D-LBA79879CAS: 36798-79-5 | Min. 95% | 106.00 €~754.00 € | Mon 30 Jun 25 |

Budralazine
Controlled ProductRef: TR-B689515
50mg | 352.00 € | ||
500mg | 2,322.00 € |

Budralazine
Ref: TM-T23834
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |

Budralazine
Ref: 3D-LBA79879
2mg | 185.00 € | ||
5mg | 254.00 € | ||
10mg | 373.00 € | ||
25mg | 531.00 € | ||
50mg | 754.00 € |